The sphingolipid ceramide, a bioeffector lipid, is known to regulate anti-proliferative and stress responses invarious human cancer cells. Studies from this project have defined a novel pathway for the generation ofceramide, 'the salvage pathway', which involves activation of acid sphingomyelinase (aSMase). Interestingly,our preliminary results show that the cytotoxic agents cisplatin, doxorubicin, and paclitaxel exert significanteffects on the adhesion and migration of cancer cells, at sub-toxic concentrations. Importantly, these resultssuggest an important role for the aSMase/ceramide pathway in regulating these responses. These data andinsights lead us to the HYPOTHESIS that the aSMase/ceramide pathway is an important mediator of stressinducers, with key roles in regulating cell migration and metastasis. Therefore, 3 specific aims are proposed:1) To define molecular mechanisms of activation of aSMase. We will focus on defining a) the role of PKC3 asan upstream kinase in regulation of aSMase; b) the biochemical and cellular mechanisms by whichphosphorylation activates the enzyme; and c) the cellular compartment where aSMase is activated. 2) Todetermine the role of aSMase in tumor growth and metastasis and response to chemotherapy by: a)establishing the role of aSMase/ceramide in cell adhesion/migration of cancer cells; b) examining anddefining the role of this pathway in tumor metastasis/growth in vivo. 3) To determine the mechanisms bywhich the aSMase/ceramide pathway mediates cell stress responses. Understanding this pathway shouldhave great impact on the field of ceramide-mediated biology precisely by beginning to untangle thecomplexity of these pathways through provision of pathway-specific insight. Equally as important, definingupstream and downstream components of this pathway, which is activated by agents of significanttherapeutic value, may result in defining novel therapeutic targets in cancer therapy. Finally, there is thetantalizing possibility that the role of this pathway in inhibition of cell migration in response tochemotherapeutic agents may lead to a re-examination of therapeutically relevant actions of these agents byfocusing on their effects on migration and metastasis rather than on cytotoxicity or proliferation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA097132-06
Application #
7534135
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M1))
Project Start
2008-09-16
Project End
2013-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
6
Fiscal Year
2008
Total Cost
$124,404
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Pulkoski-Gross, Michael J; Jenkins, Meredith L; Truman, Jean-Philip et al. (2018) An intrinsic lipid-binding interface controls sphingosine kinase 1 function. J Lipid Res 59:462-474
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Bai, Aiping; Bielawska, Alicja; Rahmaniyan, Mehrdad et al. (2018) Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites. Bioorg Med Chem 26:6067-6075
Newcomb, Benjamin; Rhein, Cosima; Mileva, Izolda et al. (2018) Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5. J Lipid Res 59:1219-1229
Espaillat, Mel Pilar; Snider, Ashley J; Qiu, Zhijuan et al. (2018) Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment. FASEB J 32:2339-2353
Hannun, Yusuf A; Obeid, Lina M (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175-191
Schwartz, Nicholas U; Linzer, Ryan W; Truman, Jean-Philip et al. (2018) Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. FASEB J 32:1716-1728
Moorthi, Sitapriya; Burns, Tara Ann; Yu, Gui-Qin et al. (2018) Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation. FASEB J 32:4270-4283
Morris, Thomas G; Borland, Samantha J; Clarke, Christopher J et al. (2018) Sphingosine 1-phosphate activation of ERM contributes to vascular calcification. J Lipid Res 59:69-78
Coant, Nicolas; García-Barros, Mónica; Zhang, Qifeng et al. (2018) AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells. Oncogene 37:3852-3863

Showing the most recent 10 out of 215 publications